These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 8077318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
    Pang S, Levine LS, Stoner E, Opitz JM, Pollack MS, Dupont B, New MI.
    J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
    [Abstract] [Full Text] [Related]

  • 3. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
    [Abstract] [Full Text] [Related]

  • 4. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
    Sakkal-Alkaddour H, Zhang L, Yang X, Chang YT, Kappy M, Slover RS, Jorgensen V, Pang S.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
    Rhéaume E, Sanchez R, Simard J, Chang YT, Wang J, Pang S, Labrie F.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1012-8. PubMed ID: 7962268
    [Abstract] [Full Text] [Related]

  • 6. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY, Lerner AJ, Stoner E, Levine LS, Oberfield SE, Engel I, New MI.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [Abstract] [Full Text] [Related]

  • 9. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L, Sakkal-Alkaddour H, Chang YT, Yang X, Pang S.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [Abstract] [Full Text] [Related]

  • 10. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT, Zhang L, Alkaddour HS, Mason JI, Lin K, Yang X, Garibaldi LR, Bourdony CJ, Dolan LM, Donaldson DL.
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [Abstract] [Full Text] [Related]

  • 11. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation.
    Lofrano-Porto A, Casulari LA, Nascimento PP, Giacomini L, Naves LA, da Motta LD, Layman LC.
    Fertil Steril; 2008 Oct; 90(4):1169-74. PubMed ID: 17961559
    [Abstract] [Full Text] [Related]

  • 12. Hyperandrogenism due to 3 beta-hydroxysteroid dehydrogenase deficiency with accessory adrenocortical tissue: a hormonal and metabolic evaluation.
    Paula FJ, Dick-de-Paula I, Pontes A, Schmitt FC, Mendonça BB, Foss MC.
    Braz J Med Biol Res; 1994 May; 27(5):1149-58. PubMed ID: 8000336
    [Abstract] [Full Text] [Related]

  • 13. Combined hypothalamic-pituitary-gonadal defect in a hypogonadic man with a novel mutation in the DAX-1 gene.
    Caron P, Imbeaud S, Bennet A, Plantavid M, Camerino G, Rochiccioli P.
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3563-9. PubMed ID: 10522996
    [Abstract] [Full Text] [Related]

  • 14. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R, Black V, Hines GA, Fox LM, Boots LR.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [Abstract] [Full Text] [Related]

  • 19. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.
    Pang S, Wang W, Rich B, David R, Chang YT, Carbunaru G, Myers SE, Howie AF, Smillie KJ, Mason JI.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213
    [Abstract] [Full Text] [Related]

  • 20. Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty.
    Mendonca BB, Bloise W, Arnhold IJ, Batista MC, Toledo SP, Drummond MC, Nicolau W, Mattar E.
    J Steroid Biochem; 1987 Dec; 28(6):669-75. PubMed ID: 2826919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.